We are live on ! Find out more
TECX

Tectonic Therapeutic

64 hedge funds and large institutions have $23.8M invested in Tectonic Therapeutic in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 26 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.66% less ownership

Funds ownership: 5.6%4.94% (-0.66%)

19% less funds holding

Funds holding: 7964 (-15)

39% less capital invested

Capital invested by funds: $38.8M → $23.8M (-$14.9M)

46% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 26

54% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 26

Holders
64
Holders Change
-15
Holders Change %
-18.99%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
12
Reduced
26
Closed
26
Calls
$26K
Puts
Net Calls
+$26K
Net Calls Change
-$160K
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$4.16M
GC
2
GMT Capital
Georgia
$3.21M +$884K +74,965 +35%
JP Morgan Chase
3
JP Morgan Chase
New York
$1.95M +$123K +10,471 +6%
BlackRock
4
BlackRock
New York
$1.84M -$1.76M -148,975 -47%
Renaissance Technologies
5
Renaissance Technologies
New York
$1.43M +$659K +55,892 +76%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$1.03M +$206K +17,509 +23%
KPF
7
K2 Principal Fund
Ontario, Canada
$1.03M +$1.1M +92,931 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$939K -$51.7K -4,390 -5%
ACM
9
Aisling Capital Management
New York
$929K
Millennium Management
10
Millennium Management
New York
$731K +$265K +22,507 +51%
FCM
11
Farallon Capital Management
California
$681K
Citadel Advisors
12
Citadel Advisors
Florida
$636K +$72.2K +6,121 +12%
MB
13
MPM BioImpact
Massachusetts
$596K
Two Sigma Advisers
14
Two Sigma Advisers
New York
$523K -$106K -8,984 -16%
RCM
15
RA Capital Management
Massachusetts
$515K +$550K +46,633 New
Morgan Stanley
16
Morgan Stanley
New York
$492K +$66.2K +5,618 +14%
Two Sigma Investments
17
Two Sigma Investments
New York
$436K -$195K -16,566 -30%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$413K -$31.8K -2,700 -7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$355K -$352K -29,902 -48%
GCP
20
GSA Capital Partners
United Kingdom
$304K -$8K -679 -2%
NLVP
21
New Leaf Venture Partners
New York
$290K
Goldman Sachs
22
Goldman Sachs
New York
$136K -$121K -10,275 -45%
State Street
23
State Street
Massachusetts
$130K -$476K -40,413 -77%
E
24
Ergoteles
New York
$128K +$137K +11,587 New
BCM
25
Bridgeway Capital Management
Texas
$124K -$96.4K -8,175 -42%

TECX Hedge Fund Activity: Q2 2022 in Review

64 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2022, worth a combined $23.8M — down 39% from $38.8M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of TECX and 14 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 12 added.

The largest buyer was K2 Principal Fund, opening a new position worth an estimated $1.1M. The largest seller was Federated Hermes, cutting an estimated $2.4M.

  • 64 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2022, down from 79 in Q1 2022.
  • Funds reported $23.8M of Tectonic Therapeutic stock for Q2 2022, down 39% quarter-over-quarter.
  • 14 funds opened new Tectonic Therapeutic positions in Q2 2022 and 26 closed out, a net change of -12 holders.
  • The largest Tectonic Therapeutic buyer in Q2 2022 was K2 Principal Fund, an estimated $1.1M added.
  • The largest Tectonic Therapeutic seller in Q2 2022 was Federated Hermes, an estimated $2.4M sold.

Based on aggregated 13F filings for Q2 2022.